Clinical validity of plasma and urinary pellet DNA monitoring for the diagnosis of recurrent bladder cancer

被引：0
|
作者：
Abe, Masakazu [1 ]
Hiraki, Hayato [1 ]
Tamura, Daichi [2 ]
Kato, Renpei [3 ]
Maekawa, Shigekatsu [3 ]
Takata, Ryo [3 ]
Obara, Wataru [3 ]
Nishizuka, Satoshi [1 ]
机构：
[1] Iwate Med Univ, Div Biomed Res & Dev, Morioka, Iwate, Japan
[2] Iwate Med Univ, Sch Med, Dept Urol, Morioka, Iwate, Japan
[3] Iwate Med Sch Med, Dept Urol, Morioka, Iwate, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3303
引用
收藏
页码：2187 / 2187
页数：1
相关论文
共 50 条
  • [41] Potential of urinary biomarkers in early bladder cancer diagnosis
    Lam, Thomas
    Nabi, Ghulam
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (08) : 1105 - 1115
  • [42] A urinary microRNA (miR) signature for diagnosis of bladder cancer
    Hofbauer, Sebastian L.
    de Martino, Michela
    Lucca, Ilaria
    Haitel, Andrea
    Susani, Martin
    Shariat, Shahrokh F.
    Klatte, Tobias
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (12) : 531.e1 - 531.e8
  • [43] Serum and urinary endocan levels for bladder cancer diagnosis
    Hu, Zhi-De
    ANNALS OF CLINICAL BIOCHEMISTRY, 2016, 53 (06) : 717 - 717
  • [44] Urinary Tumour Markers in the Diagnosis and the Surveillance of Bladder Cancer
    Binbay, Murat
    Berberoglu, Yalcin
    Yazici, Ozgur
    Akman, Tolga
    Sarilar, Omer
    Muslumanoglu, Ahmet Yaser
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2010, 48 (04): : 121 - 125
  • [45] Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
    Jin, Xing
    Yun, Seok Joong
    Jeong, Pildu
    Kim, Isaac Yi
    Kim, Wun-Jae
    Park, Sunghyouk
    ONCOTARGET, 2014, 5 (06) : 1635 - 1645
  • [46] URINARY IMMUNOGLOBULIN-A IN THE DIAGNOSIS OF BLADDER-CANCER
    BETKERUR, V
    BAUMGARTNER, G
    TALLURI, K
    SHARIFI, R
    NAGUBADI, S
    GUINAN, P
    JOURNAL OF SURGICAL ONCOLOGY, 1981, 16 (03) : 215 - 217
  • [47] Reporting on circulating tumor DNA monitoring in metastatic cancer-From clinical validity to clinical utility
    Thomsen, Caroline Brenner
    Juul, Amanda Dandanell
    Lefevre, Anna Cecilie
    Truelsen, Christina Glismand
    Dizdarevic, Edina
    Ryssel, Heidi
    Kjaer, Ina Mathilde
    Wind, Karen Lycke
    Callesen, Louise Bach
    Larsen, Louise Faaborg
    Frank, Malene Stochkel
    Andersen, Rikke Fredslund
    Spindler, Karen-Lise Garm
    Jakobsen, Anders
    CANCER, 2022, 128 (11) : 2052 - 2057
  • [48] Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer
    Banki, Farzaneh
    Yacoub, Wael N.
    Hagen, Jeffrey A.
    Mason, Rodney J.
    Ayazi, Shahin
    DeMeester, Steven R.
    Lipham, John C.
    Danenberg, Kathleen
    Danenberg, Peter
    DeMeester, Tom R.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2008, 207 (01) : 30 - 35
  • [49] Primary Adenocarcinoma of the Urinary Bladder Differential Diagnosis and Clinical Relevance
    Zhong, Minghao
    Gersbach, Elizabeth
    Rohan, Stephen M.
    Yang, Ximing J.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (03) : 371 - 381
  • [50] Glandular lesions of the urinary bladder: clinical significance and differential diagnosis
    Williamson, Sean R.
    Lopez-Beltran, Antonio
    Montironi, Rodolfo
    Cheng, Liang
    HISTOPATHOLOGY, 2011, 58 (06) : 811 - 834
12345